Ledger.Open graph →
SEC Form D · filed October 31, 2016

CURE PHARMACEUTICAL Corp

Offering
$6.0M
Sold
$6.0M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
OXNARD, CA
Type

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (18)

Vic Branstetter · Oxnard, CADirectorWayne Nasby · Oxnard, CADirectorRob Davidson · Oxnard, CAExec · DirectorIan Sephton · Oxnard, CADirectorEdward Maliski · Oxnard, CADirectorMark Udell · Oxnard, CAExecAndrew Lerner · New York, NYExec · DirectorAlex Maffeo · New York, NYDirectorLuke Ledbetter · New York, NYDirectorMegatel Capital Investment, LLC · FARMERS BRANCH, TXDirectorPatrick Hutchines · Luxembourg, LuxembourgExecVic Branstetter · Oxnard, CADirectorCharles E. Carnegie · New York, NYDirectorBob Glosson · Durham, NCExec · DirectorBarry Boniface · Durham, NCDirectorJerry Nowlin · Durham, NCDirectorMark Feidler · Durham, NCDirectorJack Barry · Durham, NCExec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗